Dr. Rosen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-497-8000- Is this information wrong?
Education & Training
- Vanderbilt University Medical CenterFellowship, Pediatric Gastroenterology, 2006 - 2009
- Vanderbilt School of MedicineMSc, 2009
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2003 - 2006
- Harvard Medical SchoolClass of 2003
- Duke UniversityBS, Biology, Summa Cum Laude, 1995 - 1999
- Duke UniversityBS, Biology, Summa Cum Laude, 1999
Certifications & Licensure
- CA State Medical License 2021 - 2025
- OH State Medical License 2013 - 2022
- KY State Medical License 2020 - 2022
- WI State Medical License 2016 - 2021
- TN State Medical License 2009 - 2015
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- Clinical Team Achievement Faculty Award CCHMC, 2018
- Elected Member Society for Pediatric Research, 2014
- Turner-Hazinski Research Award Dept. of Pediatrics, Vanderbilt Univ. Sch. of Medicine, 2013
- Join now to see all
Clinical Trials
- Anti-TNF Therapy for Refractory Colitis in Hospitalized Children Start of enrollment: 2016 May 01
Publications & Presentations
PubMed
- Real-world effectiveness of ustekinumab and vedolizumab in TNF-exposed pediatric patients with ulcerative colitis.Perseus V Patel, Amy Zhang, Balu Bhasuran, Vignesh G Ravindranath, Melvin B Heyman, Sofia G Verstraete, Atul J Butte, Michael J Rosen, Vivek A Rudrapatna> ;Journal of Pediatric Gastroenterology and Nutrition. 2024 Mar 14
- 1 citationsRecommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.Eileen Crowley, Christopher Ma, Leonard Guizzetti, Guangyong Zou, Peter J Lewindon, Michael S Gee, Jeffrey S Hyams, Michael J Rosen, Daniel von Allmen, Anthony de Buck...> ;Inflammatory Bowel Diseases. 2024 Mar 1
- 2 citationsTargeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis.Kathryn Clarkston, Rebekah Karns, Anil G Jegga, Mihika Sharma, Sejal Fox, Babajide A Ojo, Phillip Minar, Thomas D Walters, Anne M Griffiths, David R Mack, Brendan Boyl...> ;Journal of Crohn's & Colitis. 2022 Nov 23
- Join now to see all
Journal Articles
- Mucosal type 2 and type 17 gene expression distinguishes ulcerative colitis from colon-only Crohn�s disease in treatment-na�ve pediatric patientsRosen MJ, Karns R, Vallance JE, Bezold R, Waddell A, Collins MH, Haberman Y, Minar P, Baldassano RN, Hyams JS, Baker SS, Kellermayer R, Noe J, Griffiths AM, Rosh JR, C..., Gastroenterology, 1/1/2017
- Microbiota-sensitive epigenetic signature predicts inflammation in Crohn�s diseaseKelly D, Kotliar M, Woo V, Jagannathan S, Whitt J, Moncivaiz J, Aronow BJ, Dubinsky MC, Hyams JS, Markowitz JF, Baldassano RN, Stephens MC, Walters TD, Kugathasan S, H..., JCI Insight, 1/1/2017
- Join now to see all
Abstracts/Posters
- The treatment na�ve rectal transcriptome identifies pathways mediating clinical and endoscopic severity and response to initial therapy in pediatric ulcerative colitis.Haberman Y, Karns R, Dexheimer PJ, Bauman LE, Collins MH, Rosen MJ, et al., AGA Annual Scientific Meeting at DDW, Washington, DC, 1/1/2018
- IL-33 indirectly induces goblet cell hyperplasia in the murine intestine through IL-13 production by type 2 innate lymphoid cells.Waddell AP, Vallance JE, Rosen MJ., AGA Abstracts published in Gastroenterology, 1/1/2017
- Effect of an Anti-TNF Therapeutic Drug Monitoring Quality Improvement Program on Inflammatory Bowel Disease Patient Outcomes at a Large Academic Pediatric Gastroentero...Mulgund AA, Bauman L, Chona DL, Sharma P, Su W, Fei L, Denson LA, Minar P, Dykes DM, Rosen MJ., World Congress of Gastroenterology at ACG, NASPGHAN Annual Scientific Meeting, 1/1/2017
- Join now to see all
Lectures
- Cases from the WardsChildren�s Hospital Boston - 1/1/2005
- Interleukin-33 in Ulcerative Colitis: Pro-Inflammatory Cytokine or Protective ResponseCincinnati, OH - 1/10/2015
- Mucosal type 2 and type 17 gene expression distinguishes ulcerative colitis from colitis-only Crohn�s disease in treatment-na�ve pediatric patientsMt. Sterling, OH - 1/9./2016
- Join now to see all
Other
- Outcome following infliximab therapy for pediatric patients hospitalized with refractory colitis-predominant inflammatory bowel disease.Falaiye TO, Mitchell KR, Lu Z, Saville BR, Horst SN, Moulton DE, Schwartz DA, Wilson KT, Rosen MJ., Biologic Treatment of Pediatric Inflammatory Bowel Disease: A Decade of JPGN Contributions
1/1/2014
Professional Memberships
- North American Society for Pediatric Gastroenterology, Hepatology and NutritionResearch Committee
- Crohn's & Colitis Foundation of AmericaNational Pediatric Affairs Committee
- Member
Hospital Affiliations
- Lucile Packard Children's Hospital StanfordPalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: